رجوع
13
مُدرج أيضًا باسم
APNHF
OTC
نطاق اليوم
KWD 7.50
KWD 8.86
نطاق 52 أسبوعًا
KWD 5.24
KWD 9.92
حجم التداول
252
متوسط 50 يوم / 200 يوم
KWD 7.60
/
KWD 6.43
الإغلاق السابق
KWD 7.90
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -3.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | -1.3 | 3.7 |
| Net Margin % | -2.5 | 3.9 |
| Rev Growth 5Y % | 3.5 | 10.0 |
| D/E | 0.4 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 14.540
KWD 12.528 – KWD 16.948
|
44 B | 1 |
| FY2027 |
KWD 13.457
KWD 11.595 – KWD 15.686
|
41 B | 1 |
| FY2026 |
KWD 11.842
KWD 10.204 – KWD 13.804
|
44 B | 1 |
النقاط الرئيسية
Revenue grew 3.52% annually over 5 years — modest growth
Earnings declined -124.59% over the past year
Debt/Equity of 0.43 — conservative balance sheet
Generating 104.00M in free cash flow
PEG of 0.40 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.52%
النمو
Revenue Growth (5Y)
3.52%
Revenue (1Y)-3.00%
Earnings (1Y)-124.59%
FCF Growth (3Y)-78.91%
الجودة
Return on Equity
-1.28%
ROIC0.89%
Net Margin-2.50%
Op. Margin3.31%
الأمان
Debt / Equity
0.43
Current Ratio2.21
Interest Coverage0.87
التقييم
P/E Ratio
-3.07
P/B Ratio0.04
EV/EBITDA22.99
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3.00% | Revenue Growth (3Y) | 3.21% |
| Earnings Growth (1Y) | -124.59% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3.52% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 43.36B | Net Income (TTM) | -1.08B |
| ROE | -1.28% | ROA | -0.80% |
| Gross Margin | 44.11% | Operating Margin | 3.31% |
| Net Margin | -2.50% | Free Cash Flow (TTM) | 104.00M |
| ROIC | 0.89% | FCF Growth (3Y) | -78.91% |
| Safety | |||
| Debt / Equity | 0.43 | Current Ratio | 2.21 |
| Interest Coverage | 0.87 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | -3.07 | P/B Ratio | 0.04 |
| P/S Ratio | 0.08 | PEG Ratio | 0.40 |
| EV/EBITDA | 22.99 | Dividend Yield | 0.03% |
| Market Cap | 3.33B | Enterprise Value | 33.04B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 43.36B | 44.71B | 40.71B | 38.61B | 37.77B |
| Net Income | -1.08B | 4.40B | 5.23B | 6.49B | 4.81B |
| EPS (Diluted) | -2.44 | 9.91 | 11.77 | 14.32 | 10.53 |
| Gross Profit | 19.13B | 19.42B | 18.41B | 18.31B | 17.79B |
| Operating Income | 1.44B | 7.00B | 7.82B | 8.67B | 7.07B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 135.89B | 139.16B | 134.28B | 111.38B | 109.68B |
| Total Liabilities | 51.00B | 54.29B | 48.05B | 40.43B | 44.06B |
| Shareholders' Equity | 84.89B | 84.86B | 86.24B | 70.94B | 65.63B |
| Total Debt | 36.12B | 36.46B | 29.28B | 22.25B | 24.87B |
| Cash & Equivalents | 6.41B | 12.34B | 10.91B | 6.18B | 8.55B |
| Current Assets | 38.70B | 44.09B | 44.50B | 34.56B | 32.71B |
| Current Liabilities | 17.50B | 24.38B | 23.15B | 23.40B | 36.75B |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#772 of 820
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026